Jay Marcyes

Latest Updates from this link

Target buys downtown Seattle site

Target bought a site in downtown Seattle on Friday.

Omeros Lines Up $40M Financing

Omeros (NASDAQ: OMER), the Seattle-based biotech company, has struck a deal in which it may raise as much as $40 million over the next two years through selling shares of common stock to a single investor, Azimuth Opportunity. Omeros raised $68.2 million through its initial public offering in October, but securing more money at certain ...

Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News

This week, we saw more than the usual number of venture deals on the Seattle life sciences beat. Maybe the VCs needed to tie up some loose ends before unplugging in the month of August. -Seattle-based Immune Design snagged the big round of the week, a full $32 million Series B deal that included ProQuest Investments, ...